Literature DB >> 20724292

Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1.

Michael Costigan1, Inna Belfer, Robert S Griffin, Feng Dai, Lee B Barrett, Giovanni Coppola, Tianxia Wu, Carly Kiselycznyk, Minakshi Poddar, Yan Lu, Luda Diatchenko, Shad Smith, Enrique J Cobos, Dmitri Zaykin, Andrew Allchorne, Edith Gershon, Jessica Livneh, Pei-Hong Shen, Lone Nikolajsen, Jaro Karppinen, Minna Männikkö, Anthi Kelempisioti, David Goldman, William Maixner, Daniel H Geschwind, Mitchell B Max, Ze'ev Seltzer, Clifford J Woolf.   

Abstract

Not all patients with nerve injury develop neuropathic pain. The extent of nerve damage and age at the time of injury are two of the few risk factors identified to date. In addition, preclinical studies show that neuropathic pain variance is heritable. To define such factors further, we performed a large-scale gene profiling experiment which plotted global expression changes in the rat dorsal root ganglion in three peripheral neuropathic pain models. This resulted in the discovery that the potassium channel alpha subunit KCNS1, involved in neuronal excitability, is constitutively expressed in sensory neurons and markedly downregulated following nerve injury. KCNS1 was then characterized by an unbiased network analysis as a putative pain gene, a result confirmed by single nucleotide polymorphism association studies in humans. A common amino acid changing allele, the 'valine risk allele', was significantly associated with higher pain scores in five of six independent patient cohorts assayed (total of 1359 subjects). Risk allele prevalence is high, with 18-22% of the population homozygous, and an additional 50% heterozygous. At lower levels of nerve damage (lumbar back pain with disc herniation) association with greater pain outcome in homozygote patients is P = 0.003, increasing to P = 0.0001 for higher levels of nerve injury (limb amputation). The combined P-value for pain association in all six cohorts tested is 1.14 E-08. The risk profile of this marker is additive: two copies confer the most, one intermediate and none the least risk. Relative degrees of enhanced risk vary between cohorts, but for patients with lumbar back pain, they range between 2- and 3-fold. Although work still remains to define the potential role of this protein in the pathogenic process, here we present the KCNS1 allele rs734784 as one of the first prognostic indicators of chronic pain risk. Screening for this allele could help define those individuals prone to a transition to persistent pain, and thus requiring therapeutic strategies or lifestyle changes that minimize nerve injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20724292      PMCID: PMC2929335          DOI: 10.1093/brain/awq195

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  43 in total

1.  Subunit assembly and domain analysis of electrically silent K+ channel alpha-subunits of the rat Kv9 subfamily.

Authors:  M Stocker; M Hellwig; D Kerschensteiner
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

Review 2.  International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels.

Authors:  George A Gutman; K George Chandy; Stephan Grissmer; Michel Lazdunski; David McKinnon; Luis A Pardo; Gail A Robertson; Bernardo Rudy; Michael C Sanguinetti; Walter Stühmer; Xiaoliang Wang
Journal:  Pharmacol Rev       Date:  2005-12       Impact factor: 25.468

3.  Beware of a half-tailed test.

Authors:  J E Overall; H M Rhoades
Journal:  Psychol Bull       Date:  1986-07       Impact factor: 17.737

4.  Long-term outcomes of surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: 10 year results from the maine lumbar spine study.

Authors:  Steven J Atlas; Robert B Keller; Yen A Wu; Richard A Deyo; Daniel E Singer
Journal:  Spine (Phila Pa 1976)       Date:  2005-04-15       Impact factor: 3.468

Review 5.  VIP and PACAP: very important in pain?

Authors:  T Dickinson; S M Fleetwood-Walker
Journal:  Trends Pharmacol Sci       Date:  1999-08       Impact factor: 14.819

6.  Electrically silent potassium channel subunits from human lens epithelium.

Authors:  A R Shepard; J L Rae
Journal:  Am J Physiol       Date:  1999-09

7.  PSD-95 and Lin-7b interact with acid-sensing ion channel-3 and have opposite effects on H+- gated current.

Authors:  Alesia M Hruska-Hageman; Christopher J Benson; A Soren Leonard; Margaret P Price; Michael J Welsh
Journal:  J Biol Chem       Date:  2004-08-17       Impact factor: 5.157

8.  The Maine Lumbar Spine Study, Part II. 1-year outcomes of surgical and nonsurgical management of sciatica.

Authors:  S J Atlas; R A Deyo; R B Keller; A M Chapin; D L Patrick; J M Long; D E Singer
Journal:  Spine (Phila Pa 1976)       Date:  1996-08-01       Impact factor: 3.468

9.  Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception.

Authors:  J S Mogil; S G Wilson; K Bon; S E Lee; K Chung; P Raber; J O Pieper; H S Hain; J K Belknap; L Hubert; G I Elmer; J M Chung; M Devor
Journal:  Pain       Date:  1999-03       Impact factor: 6.961

10.  Changes in expression of voltage-gated potassium channels in dorsal root ganglion neurons following axotomy.

Authors:  K Ishikawa; M Tanaka; J A Black; S G Waxman
Journal:  Muscle Nerve       Date:  1999-04       Impact factor: 3.217

View more
  99 in total

1.  Orofacial pain prospective evaluation and risk assessment study--the OPPERA study.

Authors:  William Maixner; Luda Diatchenko; Ronald Dubner; Roger B Fillingim; Joel D Greenspan; Charles Knott; Richard Ohrbach; Bruce Weir; Gary D Slade
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

2.  Relax, you won't feel the pain.

Authors:  Tim Wiltshire; William Maixner; Luda Diatchenko
Journal:  Nat Neurosci       Date:  2011-11-23       Impact factor: 24.884

Review 3.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

Review 4.  What is this thing called pain?

Authors:  Clifford J Woolf
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

5.  Robust Axonal Regeneration Occurs in the Injured CAST/Ei Mouse CNS.

Authors:  Takao Omura; Kumiko Omura; Andrea Tedeschi; Priscilla Riva; Michio W Painter; Leticia Rojas; Joshua Martin; Véronique Lisi; Eric A Huebner; Alban Latremoliere; Yuqin Yin; Lee B Barrett; Bhagat Singh; Stella Lee; Tom Crisman; Fuying Gao; Songlin Li; Kush Kapur; Daniel H Geschwind; Kenneth S Kosik; Giovanni Coppola; Zhigang He; S Thomas Carmichael; Larry I Benowitz; Michael Costigan; Clifford J Woolf
Journal:  Neuron       Date:  2015-05-21       Impact factor: 17.173

Review 6.  Recent advances in the understanding of genetic susceptibility to chronic pain and somatic symptoms.

Authors:  Kate L Holliday; John McBeth
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

7.  Plasticity of DNA methylation in a nerve injury model of pain.

Authors:  Meike Gölzenleuchter; Rahul Kanwar; Manal Zaibak; Fadi Al Saiegh; Theresa Hartung; Jana Klukas; Regenia L Smalley; Julie M Cunningham; Maria E Figueroa; Gary P Schroth; Terry M Therneau; Michaela S Banck; Andreas S Beutler
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

Review 8.  Breaking barriers to novel analgesic drug development.

Authors:  Ajay S Yekkirala; David P Roberson; Bruce P Bean; Clifford J Woolf
Journal:  Nat Rev Drug Discov       Date:  2017-06-09       Impact factor: 84.694

Review 9.  Genetics of HIV-associated sensory neuropathy and related pain in Africans.

Authors:  Huguette Gaelle Ngassa Mbenda; Antonia Wadley; Zane Lombard; Catherine Cherry; Patricia Price; Peter Kamerman
Journal:  J Neurovirol       Date:  2017-05-30       Impact factor: 2.643

Review 10.  Managing Chronic Pain in Special Populations with Emphasis on Pediatric, Geriatric, and Drug Abuser Populations.

Authors:  Kyle M Baumbauer; Erin E Young; Angela R Starkweather; Jessica W Guite; Beth S Russell; Renee C B Manworren
Journal:  Med Clin North Am       Date:  2016-01       Impact factor: 5.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.